The Valley Desk

NCT02650401 · Interventional trial

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions CNS Tumors, Solid Tumors

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov